Circulating proangiogenic cell activity is associated with cardiovascular disease risk

Kreton Mavromatis, Konstantinos Aznaouridis, Ibhar Al Mheid, Emir Veledar, Saurabh Dhawan, Jonathan R Murrow, Zohreh Forghani, Diane J. Sutcliffe, Nima Ghasemzadeh, R. Wayne Alexander, W. Robert Taylor, Arshed A. Quyyumi

Research output: Contribution to journalArticle

9 Citations (Scopus)

Abstract

Vascular injury mobilizes bone marrow-derived proangiogenic cells into the circulation, where these cells can facilitate vascular repair and new vessel formation. We sought to determine the relationship between a new biomarker of circulating bone marrow-derived proangiogenic cell activity, the presence of atherosclerotic cardiovascular disease (CVD) and its risk factors, and clinical outcomes. Circulating proangiogenic cell activity was estimated using a reproducible angiogenic colony-forming unit (CFU-A) assay in 532 clinically stable subjects aged 20 to 90 years and ranging in the CVD risk spectrum from those who are healthy without risk factors to those with active CVD. CFU-A counts increased with the burden of CVD risk factors (p < 0.001). CFU-A counts were higher in subjects with symptomatic CVD than in those without (p < 0.001). During follow-up of 232 subjects with CVD, CFU-A counts were higher in those with death, myocardial infarction, or stroke than in those without (110 [70-173] vs 84 [51-136], p = 0.01). Therefore, we conclude that circulating proangiogenic cell activity, as estimated by CFU-A counts, increases with CVD risk factor burden and in the presence of established CVD. Furthermore, higher circulating proangiogenic cell activity is associated with worse clinical outcome in those with CVD.

Original languageEnglish (US)
Pages (from-to)1163-1170
Number of pages8
JournalJournal of Biomolecular Screening
Volume17
Issue number9
DOIs
StatePublished - Jan 1 2012

Fingerprint

Cardiovascular Diseases
Bone
Bone Marrow
Vascular System Injuries
Biomarkers
Blood Vessels
Assays
Repair
Stem Cells
Stroke
Myocardial Infarction

Keywords

  • biomarkers
  • cardiac diseases
  • cell-based assay
  • stem cells

ASJC Scopus subject areas

  • Analytical Chemistry
  • Biotechnology
  • Biochemistry
  • Molecular Medicine
  • Pharmacology
  • Drug Discovery

Cite this

Mavromatis, K., Aznaouridis, K., Al Mheid, I., Veledar, E., Dhawan, S., Murrow, J. R., ... Quyyumi, A. A. (2012). Circulating proangiogenic cell activity is associated with cardiovascular disease risk. Journal of Biomolecular Screening, 17(9), 1163-1170. https://doi.org/10.1177/1087057112454919

Circulating proangiogenic cell activity is associated with cardiovascular disease risk. / Mavromatis, Kreton; Aznaouridis, Konstantinos; Al Mheid, Ibhar; Veledar, Emir; Dhawan, Saurabh; Murrow, Jonathan R; Forghani, Zohreh; Sutcliffe, Diane J.; Ghasemzadeh, Nima; Wayne Alexander, R.; Robert Taylor, W.; Quyyumi, Arshed A.

In: Journal of Biomolecular Screening, Vol. 17, No. 9, 01.01.2012, p. 1163-1170.

Research output: Contribution to journalArticle

Mavromatis, K, Aznaouridis, K, Al Mheid, I, Veledar, E, Dhawan, S, Murrow, JR, Forghani, Z, Sutcliffe, DJ, Ghasemzadeh, N, Wayne Alexander, R, Robert Taylor, W & Quyyumi, AA 2012, 'Circulating proangiogenic cell activity is associated with cardiovascular disease risk', Journal of Biomolecular Screening, vol. 17, no. 9, pp. 1163-1170. https://doi.org/10.1177/1087057112454919
Mavromatis, Kreton ; Aznaouridis, Konstantinos ; Al Mheid, Ibhar ; Veledar, Emir ; Dhawan, Saurabh ; Murrow, Jonathan R ; Forghani, Zohreh ; Sutcliffe, Diane J. ; Ghasemzadeh, Nima ; Wayne Alexander, R. ; Robert Taylor, W. ; Quyyumi, Arshed A. / Circulating proangiogenic cell activity is associated with cardiovascular disease risk. In: Journal of Biomolecular Screening. 2012 ; Vol. 17, No. 9. pp. 1163-1170.
@article{af8211604aa1432daa0deee7081d5f3a,
title = "Circulating proangiogenic cell activity is associated with cardiovascular disease risk",
abstract = "Vascular injury mobilizes bone marrow-derived proangiogenic cells into the circulation, where these cells can facilitate vascular repair and new vessel formation. We sought to determine the relationship between a new biomarker of circulating bone marrow-derived proangiogenic cell activity, the presence of atherosclerotic cardiovascular disease (CVD) and its risk factors, and clinical outcomes. Circulating proangiogenic cell activity was estimated using a reproducible angiogenic colony-forming unit (CFU-A) assay in 532 clinically stable subjects aged 20 to 90 years and ranging in the CVD risk spectrum from those who are healthy without risk factors to those with active CVD. CFU-A counts increased with the burden of CVD risk factors (p < 0.001). CFU-A counts were higher in subjects with symptomatic CVD than in those without (p < 0.001). During follow-up of 232 subjects with CVD, CFU-A counts were higher in those with death, myocardial infarction, or stroke than in those without (110 [70-173] vs 84 [51-136], p = 0.01). Therefore, we conclude that circulating proangiogenic cell activity, as estimated by CFU-A counts, increases with CVD risk factor burden and in the presence of established CVD. Furthermore, higher circulating proangiogenic cell activity is associated with worse clinical outcome in those with CVD.",
keywords = "biomarkers, cardiac diseases, cell-based assay, stem cells",
author = "Kreton Mavromatis and Konstantinos Aznaouridis and {Al Mheid}, Ibhar and Emir Veledar and Saurabh Dhawan and Murrow, {Jonathan R} and Zohreh Forghani and Sutcliffe, {Diane J.} and Nima Ghasemzadeh and {Wayne Alexander}, R. and {Robert Taylor}, W. and Quyyumi, {Arshed A.}",
year = "2012",
month = "1",
day = "1",
doi = "10.1177/1087057112454919",
language = "English (US)",
volume = "17",
pages = "1163--1170",
journal = "Journal of Biomolecular Screening",
issn = "1087-0571",
publisher = "SAGE Publications Inc.",
number = "9",

}

TY - JOUR

T1 - Circulating proangiogenic cell activity is associated with cardiovascular disease risk

AU - Mavromatis, Kreton

AU - Aznaouridis, Konstantinos

AU - Al Mheid, Ibhar

AU - Veledar, Emir

AU - Dhawan, Saurabh

AU - Murrow, Jonathan R

AU - Forghani, Zohreh

AU - Sutcliffe, Diane J.

AU - Ghasemzadeh, Nima

AU - Wayne Alexander, R.

AU - Robert Taylor, W.

AU - Quyyumi, Arshed A.

PY - 2012/1/1

Y1 - 2012/1/1

N2 - Vascular injury mobilizes bone marrow-derived proangiogenic cells into the circulation, where these cells can facilitate vascular repair and new vessel formation. We sought to determine the relationship between a new biomarker of circulating bone marrow-derived proangiogenic cell activity, the presence of atherosclerotic cardiovascular disease (CVD) and its risk factors, and clinical outcomes. Circulating proangiogenic cell activity was estimated using a reproducible angiogenic colony-forming unit (CFU-A) assay in 532 clinically stable subjects aged 20 to 90 years and ranging in the CVD risk spectrum from those who are healthy without risk factors to those with active CVD. CFU-A counts increased with the burden of CVD risk factors (p < 0.001). CFU-A counts were higher in subjects with symptomatic CVD than in those without (p < 0.001). During follow-up of 232 subjects with CVD, CFU-A counts were higher in those with death, myocardial infarction, or stroke than in those without (110 [70-173] vs 84 [51-136], p = 0.01). Therefore, we conclude that circulating proangiogenic cell activity, as estimated by CFU-A counts, increases with CVD risk factor burden and in the presence of established CVD. Furthermore, higher circulating proangiogenic cell activity is associated with worse clinical outcome in those with CVD.

AB - Vascular injury mobilizes bone marrow-derived proangiogenic cells into the circulation, where these cells can facilitate vascular repair and new vessel formation. We sought to determine the relationship between a new biomarker of circulating bone marrow-derived proangiogenic cell activity, the presence of atherosclerotic cardiovascular disease (CVD) and its risk factors, and clinical outcomes. Circulating proangiogenic cell activity was estimated using a reproducible angiogenic colony-forming unit (CFU-A) assay in 532 clinically stable subjects aged 20 to 90 years and ranging in the CVD risk spectrum from those who are healthy without risk factors to those with active CVD. CFU-A counts increased with the burden of CVD risk factors (p < 0.001). CFU-A counts were higher in subjects with symptomatic CVD than in those without (p < 0.001). During follow-up of 232 subjects with CVD, CFU-A counts were higher in those with death, myocardial infarction, or stroke than in those without (110 [70-173] vs 84 [51-136], p = 0.01). Therefore, we conclude that circulating proangiogenic cell activity, as estimated by CFU-A counts, increases with CVD risk factor burden and in the presence of established CVD. Furthermore, higher circulating proangiogenic cell activity is associated with worse clinical outcome in those with CVD.

KW - biomarkers

KW - cardiac diseases

KW - cell-based assay

KW - stem cells

UR - http://www.scopus.com/inward/record.url?scp=84866383441&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84866383441&partnerID=8YFLogxK

U2 - 10.1177/1087057112454919

DO - 10.1177/1087057112454919

M3 - Article

VL - 17

SP - 1163

EP - 1170

JO - Journal of Biomolecular Screening

JF - Journal of Biomolecular Screening

SN - 1087-0571

IS - 9

ER -